Retour sur lavenir.net
   ACKERMANS V.HAAREN 265.800 € (+0,91 %)     ARGENX SE 763.000 € (+0,66 %)     SOFINA 214.600 € (+0,75 %)     XIOR 26.500 € (+0,76 %)     CELYAD ONCOLOGY 0.284 € (+9,23 %)     KBC 110.600 € (-0,32 %)     WDP 21.820 € (+1,49 %)     SHURGARD 23.700 € (+2,60 %)     RETAIL ESTATES 70.300 € (0,00 %)     MONTEA 66.500 € (+1,53 %)     AEDIFICA 70.100 € (+2,11 %)     COFINIMMO 81.750 € (+1,11 %)     ABO GROUP 4.380 € (-2,67 %)     AB INBEV 70.440 € (+0,80 %)     BQUE NAT. BELGIQUE 368.000 € (-1,60 %)     PROXIMUS 6.475 € (+1,25 %)     VIOHALCO 19.300 € (-2,62 %)     SYENSQO 64.700 € (+1,01 %)     GBL 80.350 € (0,00 %)     KINEPOLIS GROUP 32.850 € (+6,48 %)     BPOST 1.690 € (+0,36 %)     JENSEN-GROUP 87.200 € (+2,59 %)     AGFA-GEVAERT 0.426 € (-0,82 %)     CAMPINE 227.000 € (+0,89 %)     EVS BROADC.EQUIPM. 30.500 € (+1,67 %)     KBC ANCORA 75.700 € (+0,13 %)     FAGRON 24.700 € (+1,23 %)     COLRUYT 34.680 € (+1,58 %)     BARCO 8.575 € (+0,70 %)     ONWARD MEDICAL 2.655 € (-1,85 %)     BANQUP GROUP 1.505 € (-4,14 %)     ATENOR 1.695 € (-0,88 %)     MELEXIS 78.800 € (-0,51 %)     CMB.TECH 13.120 € (+4,46 %)     EXMAR 11.500 € (-0,86 %)     CARE PROPERTY INV. 12.380 € (+1,48 %)     IBA 17.100 € (+1,18 %)     AZELIS GROUP 10.390 € (+0,68 %)     GIMV 44.350 € (+1,84 %)     VGP 79.100 € (+0,76 %)     DEME GROUP 181.200 € (+1,12 %)     D'IETEREN GROUP 165.000 € (+1,98 %)     NYRSTAR 0.070 € (-3,57 %)     ENERGYVISION 13.460 € (+0,15 %)     NYXOAH 1.336 € (-1,76 %)     ASCENCIO 50.500 € (-0,39 %)     CENERGY 23.320 € (-0,17 %)     CIE BOIS SAUVAGE 303.000 € (+0,33 %)     BREDERODE 101.000 € (0,00 %)     TESSENDERLO 19.620 € (-0,41 %)     WERELDHAVE BELGIUM 52.600 € (+2,73 %)     TUBIZE-FIN 230.800 € (+0,87 %)     LOTUS BAKERIES 11 560.000 € (+3,03 %)     RECTICEL 10.500 € (-0,94 %)     TITAN S.A. 48.160 € (+0,12 %)     BEKAERT 40.000 € (-1,96 %)     UMICORE 21.980 € (-2,22 %)     DECEUNINCK 2.245 € (+2,05 %)     SIPEF 96.000 € (+1,48 %)     TINC 11.800 € (+0,85 %)  
   GETLINK SE 18.380 € (+0,77 %)     ENGIE 26.940 € (+0,67 %)     ORANGE 18.020 € (+2,07 %)     EXEL INDUSTRIES 23.900 € (-2,45 %)     CARREFOUR 16.325 € (+0,37 %)     SAFRAN 291.500 € (-1,39 %)     SANOFI 76.010 € (-1,34 %)     AHOLD DEL 36.180 € (+1,20 %)     SAINT GOBAIN 74.320 € (-1,51 %)     SOITEC 125.350 € (-10,56 %)     FOUNTAINE PAJOT 97.200 € (-1,22 %)     WOLTERS KLUWER 63.080 € (-1,90 %)     DANONE 66.340 € (+1,59 %)     ESSILORLUXOTTICA 178.600 € (-0,61 %)     PROSUS 39.900 € (+0,15 %)     VINCI 122.850 € (+0,08 %)     AXA 40.530 € (+0,90 %)     ASML HOLDING 1 507.200 € (-0,08 %)     AIRBUS 174.960 € (-0,44 %)     COMPAGNIE ODET 1 454.000 € (+0,83 %)     PERNOD RICARD 63.060 € (-0,50 %)     LHYFE 2.000 € (+0,81 %)     LISI 62.900 € (-0,32 %)     MICHELIN 32.450 € (+1,06 %)     MEDIANTECHNOLOGIES 4.760 € (-4,23 %)     L'OREAL 384.050 € (-0,13 %)     HERMES INTL 1 635.500 € (-1,80 %)     IT LINK 16.800 € (0,00 %)     OCI 3.624 € (-0,71 %)     STMICROELECTRONICS 61.330 € (-0,31 %)     LVMH 487.650 € (-0,94 %)     CAPGEMINI 99.600 € (-0,90 %)     SCHNEIDER ELECTRIC 257.700 € (-2,18 %)     VEOLIA ENVIRON. 34.700 € (+1,67 %)     CEGEDIM 11.260 € (+0,72 %)     TOTALENERGIES 77.240 € (+1,01 %)     ING GROEP N.V. 25.050 € (-0,36 %)     BOIRON 28.600 € (-0,35 %)     AIR LIQUIDE 167.720 € (-0,42 %)     ACCOR 45.100 € (-1,14 %)     PHARMING GROUP 1.082 € (-1,23 %)     GROUPE SFPI 2.160 € (+1,41 %)     QUADIENT 12.380 € (-0,64 %)     BOLLORE 5.410 € (-1,01 %)     WERELDHAVE 20.500 € (+0,74 %)     UNILEVER 51.010 € (+2,75 %)     ADYEN 803.100 € (-2,43 %)     TONNER DRONES 0.033 € (+6,09 %)     ROCTOOL 1.185 € (-6,69 %)     KERING 256.000 € (+0,31 %)     MASTRAD 0.005 € (0,00 %)     SOLUTIONS 30 SE 0.723 € (0,00 %)     ATLAND 38.500 € (-1,03 %)     BNP PARIBAS ACT.A 91.960 € (-1,53 %)     PHILIPS KON 22.460 € (-1,40 %)     BOUYGUES 48.890 € (+0,66 %)     EXAIL TECHNOLOGIES 118.800 € (-3,96 %)     VICAT 59.500 € (+0,51 %)     LOUIS HACHETTE 1.780 € (+0,96 %)     BE SEMICONDUCTOR 288.800 € (+0,59 %)  
News Réglementées
10/06/2026 11:49

Medartis wins the Swiss Medtech Award 2026

Medartis Holding AG / Key word(s): Miscellaneous
Medartis wins the Swiss Medtech Award 2026

10.06.2026 / 11:49 CET/CEST


PRESS RELEASE

Bern, 10 June 2026: Medartis Holding AG (MED:SW), the Basel-based orthopaedic company specialising in head and extremity surgery, has been named the winner of the Swiss Medtech Award 2026. The prize recognises outstanding achievements within the Swiss medical technology industry and was presented today at Swiss Medtech Day in Bern.

First presented in 2018, the Swiss Medtech Award carries prize money of CHF 50’000 and is presented annually by the industry association Swiss Medtech. An independent jury chaired by Dr. Gery Colombo evaluates candidates on the basis of patient benefit, improvements in healthcare and technological pioneering spirit.

Medartis has been developing and manufacturing high-precision titanium implant systems for head surgery and for the upper and lower extremities for almost 30 years. The company works closely with surgeons and operating theatre personnel to develop patient-oriented implant systems and digital planning tools designed to simplify surgical procedures and reduce the risk of complications. Medartis also maintains a long-standing commitment to surgical training and continuing education, supporting the transfer of knowledge in its core areas worldwide.

 

Matthias Schupp, CEO of Medartis, commented: “This recognition belongs to our employees, our partners and to the surgeons who work with us and rely on these systems every day. It reflects a sustained focus on clinical relevance and innovation. At Medartis, innovation and the willingness to pursue disruptive ideas are non-negotiable; they are what earn us the right to win in our markets.”

 

Medartis extends its congratulations to fellow finalists Positrigo and Symbios Orthopédie and thanks Swiss Medtech and the jury for the recognition.

 

 

Download: Pictures from the award-winning ceremony.

 

Your contact:

Medartis Corporate Communications

Fabian Hildbrand, Head of Corporate Communications, investor.relations@medartis.com

Andreas Richter, Corporate Communications Manager, corporate.communication@medartis.com

+41 61 633 37 36 / +41 61 633 37 34

 

About Medartis

Founded in 1997 and headquartered in Basel, Switzerland, the Medartis Group is one of the world's leading manufacturers and providers of medical devices for surgical fixation of bone fractures and joint replacement for upper and lower extremities as well as for the craniomaxillofacial region. The Group has manufacturing sites in Switzerland, the United States, Brazil, and France. Medartis employs approx. 1,400 individuals across 12 countries, with products offered in over 60 countries globally. Medartis is committed to providing surgeons and operating theatre personnel with the most innovative implants and instruments as well as best-in-class service. For more information, please visit www.medartis.com.



End of Media Release
View original content: EQS News


Language:English
Company:Medartis Holding AG
Hochbergerstrasse 60E
4057 Basel
Switzerland
Phone:+41 61 633 34 34
Fax:+41 61 633 34 00
E-mail:info@medartis.com
Internet:www.medartis.com
ISIN:CH0386200239
Valor:38620023
Listed:SIX Swiss Exchange
EQS News ID:2342730

 
End of NewsEQS News Service

2342730  10.06.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière